Ideas to Action:

Independent research for global prosperity

CGD in the News

Biometric IDs can be 'gamechanger' in coronavirus antibody tests, vaccine (Reuters)

April 8, 2020

From the article:

“…Now, firms such as iRespond and Simprints - a UK-based nonprofit that develops biometric IDs for health and humanitarian use - are adapting their technology for the next steps.

More than 1 billion people worldwide have no way of proving their identity, according to the World Bank.

This will present a massive challenge for governments trying to ascertain who has received the vaccine, said Prashant Yadav, a senior fellow at the U.S.-based Center for Global Development.

‘The initial COVID-19 vaccine supply will be limited, so it will be essential to verify each dose reaches a real patient. Corruption, leakage, and even accidental duplication waste precious supply and are deadly,’ he said.’

Biometric digital IDs can be a gamechanger. They can help governments target population segments e.g. healthcare professionals or elderly population, verify people who have received vaccination, and have a clear record,’ he said…”

Source Location

Related Experts

Photo of Prashant Yadav
Senior Fellow